Skip to main content
TipRanks
Go Ultimate75% OFF

Paul Blake. Insider Profile

4 Followers

Paul Blake., Chief Development Officer at Oxford BioMedica, holds 2.62M shares in Oxford BioMedica (Ticker: OXBDF), holds 70.35K shares in COSCIENS Biopharma (Ticker: CSCIF). Most recently, Paul Blake. Bought ― shares of Oxford BioMedica on Mar 16, 2015 for an estimated value of $10.00K.

Paul Blake.'s Trading History

OXBDF
Oxford BioMedica
Mar 16, 2015Chief Development OfficerInformative Buy10.00K$18.33M
CSCIF
COSCIENS Biopharma
Sep 28, 2011FormerInformative Buy8.10K$412.60K

You May Also Like

Paul Blake. insider profile FAQ

What is the percentage of profitable transactions made by Paul Blake.?
The percentage of profitable transactions made by Paul Blake. is 80%.
What is the average return per transaction made by Paul Blake.?
The average return per transaction made by Paul Blake. is 115.90%.
What stocks does Paul Blake. hold?
Paul Blake. holds: OXBDF, CSCIF stocks.
What was Paul Blake.’s latest transaction?
Paul Blake.’s latest transaction was an Informative Buy of $10.00K.
What was Paul Blake.'s most profitable transaction?
Paul Blake.’s most profitable transaction was an Informative Buy of OXBDF stock on July 1, 2014. The return on the trade was 267.50%.
What is Paul Blake.'s role in Oxford BioMedica?
Paul Blake.'s role in Oxford BioMedica is Chief Development Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.